#TargetValidation
🚨 Upcoming SMR drug discovery event! 📣📣📣

🎯 Target ID and validation
🗓️ Oct 24, 2025
📍 Cambridge, UK
🔗 www.smr.org.uk/Meetings/202...

Please share widely!

#DrugDiscovery #TargetValidation #Pharma #Biotech #LifeSciences #SMR
August 8, 2025 at 11:48 AM
Very happy to have been able to contribute to this amazing story! Check out the paper at Nature Communications and the 🧵 by @nckvalerie.bsky.social below 👇. We believe #CeTeam will be an invaluable tool for #drugdiscovery and #targetvalidation in #cells

🔗: www.nature.com/articles/s41...
December 11, 2024 at 7:20 PM
March 24, 2026 at 2:00 PM
8/9 Next card: LRRK2 Frontier Structure
9/9 #TAC #Cardio #TargetValidation
April 8, 2026 at 1:10 PM
8/9 Next: CETP’s Surrogate Illusion
Full series now live in Open TAC Gallery
9/9 #TAC #TargetValidation #Alzheimers
April 7, 2026 at 12:20 PM
1/9 Starting today, we launch the TAC Signature Cards series.
First card: PCSK9 — Hypercholesterolemia
Topology Status: Cross-layer closure complete
Signature: AAA Closed Topology
T/Φ/Σ all Strong → this is the perfect closed structure we want to see.
#TAC #TargetValidation
April 4, 2026 at 3:50 PM
🔬February New Releases
🚀1,000+ new molecules for #Oncology, #Neurology, #Immunology, #Cardiovascular studies.
Key targets: #Hsp70, #MDM2, #EGFR/HER2, #M4, #Keap1-Nrf2, #IP6K. Includes first-in-class & clinical-stage compounds to boost #DrugDiscovery & #TargetValidation.
March 12, 2026 at 8:00 AM
🧪 As a complement to CCT251545 and CCT251921, the study also highlights MSC2530818 as a valuable orthogonal CDK8/19 probe, further strengthening confidence in on-target effects and enabling robust mechanistic studies.
#ChemicalProbes #CDK8 #TargetValidation
July 4, 2025 at 10:59 AM
📣 Happening today!
Join the Babraham Distinguished Lecture with Prof Paul Workman | 1–2pm, 12 June
🧬 “Probing and drugging stress pathways: Chemical Biology and therapeutic discovery”
#Cancer#StressResponse#DrugDiscovery#ChemicalBiology #TargetValidation#MolecularPharmacology #TranslationalResearch
Last chance to register for our next distinguished lecture! 🎟️
We're excited to be welcoming Prof Paul Workman as the next speaker in our distinguished lecture series! Paul will cover the 15-year rollercoaster journey to discover the cancer drug NXP800 and its mechanisms 🧪

Register now to join us on 12th June: www.babraham.ac.uk/seminars/202...
June 11, 2025 at 8:19 AM